HERON THERAPEUTICS, INC. /DE/ - COM (HRTX)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
122M
Holdings value Q3 2024
$242M
Value change Q3 2024
-$29.2M
Grand Portfolio weight change Q3 2024
0%
Number of holders
168
Number of buys Q3 2024
83
Number of sells Q3 2024
-74
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 122M $242M -$29.2M $1.99 168
2024 Q2 130M $454M +$35.4M $3.50 190
2024 Q1 119M $330M +$19.7M $2.77 157
2023 Q4 112M $191M +$1.07M $1.70 149
2023 Q3 118M $122M +$20M $1.03 137
2023 Q2 98.6M $114M -$11.7M $1.16 142
2023 Q1 108M $163M -$15.7M $1.51 152
2022 Q4 116M $289M -$29.9M $2.50 175
2022 Q3 122M $514M +$46M $4.22 177
2022 Q2 115M $321M +$4.83M $2.79 162
2022 Q1 109M $620M -$95.4M $5.72 181
2021 Q4 118M $1.07B +$78.4M $9.13 195
2021 Q3 108M $1.16B +$41.6M $10.69 190
2021 Q2 104M $1.61B +$202M $15.52 185
2021 Q1 89.8M $1.46B -$11.2M $16.21 186
2020 Q4 90.3M $1.91B +$26.5M $21.16 180
2020 Q3 90.9M $1.35B +$33.1M $14.82 175
2020 Q2 88.6M $1.33B -$51.2M $14.71 185
2020 Q1 92.1M $1.08B -$132M $11.74 188
2019 Q4 99M $2.33B +$184M $23.50 194
2019 Q3 91.4M $1.69B -$43.7M $18.50 175
2019 Q2 93.9M $1.74B +$2.23M $18.59 170
2019 Q1 92.7M $2.26B +$28.8M $24.44 191
2018 Q4 91.4M $2.37B +$92.4M $25.94 169
2018 Q3 87.5M $2.77B +$132M $31.65 187
2018 Q2 77.2M $3B +$217M $38.85 196
2018 Q1 72.6M $2B +$343M $27.60 151
2017 Q4 60.5M $1.1B +$103M $18.10 122
2017 Q3 63.4M $1.02B -$88.4M $16.15 101
2017 Q2 69.6M $964M +$51.7M $13.85 102
2017 Q1 71.2M $1.07B +$338M $15.00 95
2016 Q4 52.6M $689M +$4.71M $13.10 91
2016 Q3 51.3M $883M +$71.9M $17.23 88
2016 Q2 47M $848M +$35.4M $18.05 89
2016 Q1 45M $855M -$8.62M $18.99 98
2015 Q4 45.4M $1.21B +$39.8M $26.70 104
2015 Q3 43.7M $1.06B +$174M $24.40 100
2015 Q2 36.1M $1.13B +$319M $31.16 85
2015 Q1 26.3M $383M +$30.8M $14.55 65
2014 Q4 24.6M $247M +$1.11M $10.06 62
2014 Q3 24.4M $203M -$7.13M $8.33 56
2014 Q2 26.6M $327M +$69.9M $12.32 66
2014 Q1 20.8M $289M +$284M $13.91 40